• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE TEX® VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Catalog Number ST6L
Device Problem Insufficient Information (3190)
Patient Problems Abscess (1690); Fistula (1862); Incontinence (1928); Unspecified Infection (1930); Inflammation (1932); Pain (1994)
Event Date 11/03/2006
Event Type  Injury  
Event Description
It was reported to gore that a patient alleges to have experienced infections, pain, incontinence, fistulas, inflammation, and abscess after having been implanted with a gore-tex vascular graft in the vaginal area.Reason for implant was cystocele.
 
Manufacturer Narrative
Review of device manufacturing record history confirmed device met pre-release specifications.Ifu indications for use states the following: gore-tex vascular grafts are intended for use as vascular prostheses for replacement or bypass of diseased vessels in patients suffering occlusive or aneurysmal diseases, in trauma patients requiring vascular replacement, for dialysis access, or for other vascular procedures.
 
Event Description
On (b)(6) 1998, patient presented with cystocele and stress incontinence.Anterior repair and pereyra procedure with cystoscopy was performed.A gore-tex vascular graft was implanted in the vaginal mucosa.On (b)(6) 2006, it was noted that no foreign bodies or fistula was observed during cystoscopy.On (b)(6) 2006, two prolene sutures were found and removed during the suprapubic exploration and cystoscopy of bladder.During a cystoscopy on (b)(6) 2006, a gore-tex material was found that was implanted during a urethropexy performed years ago.Operative report dated (b)(6) 2006 states that patient presented with a recurrent pelvic abscess.Upon dissection, a granulomatous-type inflammatory tract was found and carried down to about 1cm of the gore-tex graft bolster.The tract was removed and debridement was done above and below the fascia.The wound was irrigated with kantrex antibiotic solution.A drain was placed.No complications were noted.
 
Manufacturer Narrative
The sterilization records for lot# 495282 are unavailable for review.Based on a manufacture date of 10/18/1995, the required record retention period of 10 years have been exceeded.Although documents are unavailable, standard manufacturing procedures require lot history review before release of the sterilization batch to ensure compliance with device specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE TEX® VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86001
Manufacturer Contact
genevieve begay
1500 n. 4th street
flagstaff, AZ 86004
9285263030
MDR Report Key3814222
MDR Text Key17931658
Report Number2017233-2014-00255
Device Sequence Number1
Product Code DSY
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K802095
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative,company representative
Reporter Occupation Patient
Type of Report Initial,Followup,Followup
Report Date 09/15/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/18/2000
Device Catalogue NumberST6L
Device Lot Number495282
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received05/15/2014
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received07/29/2014
10/29/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/18/1995
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age74 YR
Patient Weight70
-
-